Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ganjian S et al. - Imiquimod has rapidly been recognized as a potential candidate for off-label use. Although the FDA has approved imiquimod only for the treatment of external genital and perianal warts, actinic keratoses, and superficial basal cell carcinoma, successful clinical studies teach the greater potential and efficacy of imiquimod in treating more cutaneous viral lesions.


Today in Clinical Pharmacology...keeping you current

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

A practical approach to using methotrexate
Dermatology in Practice, 10/09/09

Ustekinumab for the treatment of plaque psoriasis
Expert Review of Dermatology, 10/13/09

Today in Dermatologic Oncology...keeping you current

A practical approach to using methotrexate
Dermatology in Practice, 10/09/09

Positron emission tomography in early detection of relapse in high-risk melanoma patients: a retrospective review
Community Oncology , 10/09/09

Surgical excision margins for primary cutaneous melanoma
Cochrane Reviews, 10/09/09

Today in Dermatopathology...keeping you current

Erysipeloid: a review
Clinical and Experimental Dermatology, 09/18/09

Update on oral lichen planus
Expert Review of Dermatology, 10/14/09

A practical approach to using methotrexate
Dermatology in Practice, 10/09/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address